{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_16640", "batch_size": 260, "batch_pos": 164, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment neutrally describes the focus of a trial ('would likely focus on safety and immune response').", "method": "llm_batch", "batch_id": "batch_2_9260", "batch_size": 260, "batch_pos": 160, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "Hypothetical outcome, not realised impact.", "method": "llm_batch", "batch_id": "batch_3_17104", "batch_size": 260, "batch_pos": 134, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "Segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_15972", "batch_size": 260, "batch_pos": 130, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "This segment discusses the focus of a trial but provides no explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_4508", "batch_size": 260, "batch_pos": 129, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_15536", "batch_size": 260, "batch_pos": 122, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_14876", "batch_size": 260, "batch_pos": 115, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes the focus of a potential future trial related to vaccine development ('would likely focus on safety and immune response') without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_14816", "batch_size": 260, "batch_pos": 85, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
